Skip to main content

tavneos

tavneos: sourced relationships with 1 company · 1 FDA decision.

tavneos evidence translation

What we can confirm

What it means

Source-backed records connect tavneos to CCXI; that link alone does not prove the drug works.

What to watch

Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected

Prepared research question

How could tavneos → CCXI affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 0 study sponsors

Related indications

Lupus nephritis (LN)

Study sponsors

No additional listed-company sponsor is linked.

Dated Pipeline Records (1)
CompanyDated record stage
ChemoCentryx, Inc. (CCXI)
developer · Reported 2022-03-01 · Current development: unknownSource
Lupus nephritis (LN)
Preclinical
FDA Decisions1 records
NDA214487Type 1 - New Molecular EntityOrphan DrugStandardOralCapsule

Frequently asked questions

Which companies have sourced relationships with tavneos?

tavneos has dated SEC/FDA relationship records for ChemoCentryx, Inc..

What is tavneos's latest FDA decision?

The most recent tracked FDA decision for tavneos is Approval, dated October 7, 2021.